Aldh1A1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ALDH1A1 Gene is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, ion transport, protein homeostasis, or stress response mechanisms.
Dysregulation or mutations in this gene contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
ALDH1A1 encodes aldehyde dehydrogenase 1A1, a cytosolic enzyme that catalyzes the oxidation of aldehydes to carboxylic acids. It plays critical roles in detoxification of lipid peroxidation products (such as 4-hydroxynonenal), retinol metabolism, and conversion of retinol to retinoic acid.[1]
In the brain, ALDH1A1 is particularly important in dopaminergic neurons where it protects against aldehyde toxicity generated during dopamine metabolism. The enzyme also produces retinoic acid, which is essential for neuronal development and plasticity.[2]
ALDH1A1 deficiency has been implicated in Parkinson's disease pathogenesis. Reduced ALDH1A1 activity in the substantia nigra of PD patients leads to accumulation of toxic aldehydes, contributing to dopaminergic neuron death. ALDH1A1 is also a marker for dopaminergic neuron progenitors in stem cell therapies.[3]
Mutations in ALDH1A1 (along with ALDH1A2 and ALDH2) can contribute to this syndrome, though it is primarily caused by ALDH3A2 mutations. The syndrome involves ichthyosis, neurological dysfunction, and retinal abnormalities.[4]
ALDH1A1 polymorphisms affect alcohol metabolism and may influence alcohol sensitivity and addiction risk. The enzyme participates in the oxidation of acetaldehyde produced by alcohol dehydrogenase.[5]
ALDH1A1 is expressed in multiple brain regions:
ALDH1A1 is also expressed in neural stem cells and is used as a marker for dopaminergic neuron differentiation.[6]
The study of Aldh1A1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wey MC, et al. J Neurochem. 2012;122(2):359-369.
[2] Jacobs FM, et al. Development. 2013;140(22):4399-4409.
[3] Galter D, et al. Exp Neurol. 2010;223(2):472-476.
[4] Maeda A, et al. Prog Retin Eye Res. 2011;30(5):342-359.
[5] Edenberg HJ, et al. Pharmacogenomics J. 2014;14(4):323-330.